phosphatidylethanolamine

(redirected from Phosphatidyl ethanolamine)
Also found in: Dictionary.

phosphatidylethanolamine

 [fos″fah-ti″dil-eth″ah-nol´ah-mēn]
a phospholipid containing ethanolamine that is a major constituent of cell membranes and is localized preferentially in the inner surface of the plasma membrane. Abbreviated PE.

phos·pha·ti·dyl·eth·a·nol·a·mine (PtdEth),

(fos'fă-tī'dĭl-eth'ă-nol'ă-mēn),
The condensation product of a phosphatidic acid and ethanolamine; found in biomembranes.
See also: cephalin.
References in periodicals archive ?
Commercial lecithin is a mixture of several natural phospholipids (phosphatidyl choline, phosphatidyl inositol, phosphatidyl ethanolamine, and phosphatidic acid) in oil.
The methyltransferase genes were arsenic(+III oxidation state) methyltransferase (AS3MT), DNA-methyltransferase la and 3b (DNMT la and DNMT3b), phosphatidyl ethanolamine N-methyltransferase (PEMT), and betaine-homocysteine methyltransferase (BHMT).
Phosphatidyl ethanolamine (PE), phosphatidyl choline (PC), phosphatidyl inositol (PI) phosphatidyl serine (PS), sphingomyelin (SPH) and lysophosphatidyl choline (LPC), fatty acids C14:0, C14:1, C16:0, C17:0, C18:0, C18:1, C18:2, C18:3, C20:4, C22:4 and C22:6 standards were bought from Sigma-Aldrich Chemical Co.
Junovan (mifamurtide - Liposomal Muramyl Tripeptide Phosphatidyl Ethanolamine MTP-PE) is selectively delivered to marcrophages via the scavenger lipoprotein receptor pathway, activating the tumoricidal activity through the cytoplasmic Nod2 receptor.
The selected genes for ACP ddRT-PCR analysis validation were insulin like growth factor 3, phosphatidyl ethanolamine binding protein, ATP synthase F0 and complement component CD.
Mepact (Mifamurtide - Liposomal Muramyl Tripeptide Phosphatidyl Ethanolamine, L-MTP-PE) is a fully synthetic lipophilic derivative of muramyl dipeptide.
Junovan (Mifamurtide - Liposomal Muramyl Tripeptide Phosphatidyl Ethanolamine, MTP-PE) is a fully synthetic lipophilic derivative of the muramyl dipeptide.
Nasdaq:EPMN), announces that the Phase III clinical results for its Liposomal Muramyl Tripeptide Phosphatidyl Ethanolamine product (L-MTP-PE), also named Mepact(TM), will be presented and discussed in a panel symposium on May 16 in Washington, DC.